Objective: Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation method that is used to study brain function and conduct neuropsychiatric therapy. Computational methods that are commonly used for electric field (E-field) dosimetry of TMS are limited in accuracy and precision because of possible geometric errors introduced in the generation of head models by segmenting medical images into tissue types. This paper studies E-field prediction fidelity as a function of segmentation accuracy.
Approach: The errors in the segmentation of medical images into tissue types are modeled as geometric uncertainty in the shape of the boundary between tissue types. For each tissue boundary realization, we then use an in-house boundary element method to perform a forward propagation analysis and quantify the impact of tissue boundary uncertainties on the induced cortical E-field.
Main Results: Our results indicate that predictions of E-field induced in the brain are negligibly sensitive to segmentation errors in scalp, skull and white matter, compartments. In contrast, E-field predictions are highly sensitive to possible CSF segmentation errors. Specifically, the segmentation errors on the CSF and gray matter interface lead to higher E-field uncertainties in the gyral crowns, and the segmentation errors on CSF and white matter interface lead to higher uncertainties in the sulci. Furthermore, the uncertainty of the average cortical E-fields over a region exhibits lower uncertainty relative to point-wise estimates.
Significance: The accuracy of current cortical E-field simulations is limited by the accuracy of CSF segmentation accuracy. Other quantities of interest like the average of the E-field over a cortical region could provide a dose quantity that is robust to possible segmentation errors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357859 | PMC |
http://dx.doi.org/10.1088/1741-2552/ac52d1 | DOI Listing |
Alzheimers Dement
December 2024
Department of Clinical Sciences Lund, Lund University, Lund, Lund, Sweden
Background: The medial temporal lobe (MTL) is the epicenter of both primary and concomitant molecular pathologies in Alzheimer’s disease (AD). The intricate anatomy of the MTL has been the subject of extensive study over the past two centuries. However, current PET and MRI AD biomarkers use often crude parcellations of the MTL that have not been sufficiently validated vis‐à‐vis anatomical ground truth.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of California, San Diego, San Diego, CA, USA
Background: Older adults with epilepsy represent the largest and fastest‐growing segment of individuals with epilepsy and harbor risk factors for pathological aging, including cerebrovascular risk factors (CVRFs) and Alzheimer’s disease (AD)‐related pathology. In fact, several community‐based studies have reported up to a 3‐fold increased risk for dementia including AD among individuals with epilepsy. Despite this, identification of risk factors for AD and related dementias (ADRD) remains largely unexplored in epilepsy, which has critical implications for patient care and dementia risk stratification.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
NYU Grossman School of Medicine, New York, NY, USA
Background: FreeSurfer is widely used for monitoring neurodegeneration by quantifying MRI brain regions vulnerable to atrophic changes associated with Alzheimer’s disease (AD). FreeSurfer test‐retest reliability has been explored mainly in younger adults, but the reliability of AD imaging biomarkers is less well studied. We used two closely spaced T1‐weighted MRIs in 100 older adults to assess FreeSurfer 7.
View Article and Find Full Text PDFBackground: Detection and quantification of White Matter Hyperintensities (WMH) are clinically important across multiple CNS disorders and neurodegenerative dementias. However, the prohibitively labor‐intensive nature of manual segmentation limits widespread clinical application. Accurate automated methods for segmenting WMH are needed to overcome this unmet clinical need.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
Background: Identifying early pathological changes in Alzheimer’s Disease (AD), and accounting for variability in progression between individuals, is crucial for timely and effective intervention. While Amyloid‐b, tau, and neuronal loss are core pathological processes in AD with established biomarkers, myelin alterations have been shown to occur but remain under‐investigated. The T1/T2w ratio represents an accessible MRI‐based marker, providing a potential proxy measure of myelin integrity.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!